Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
基本信息
- 批准号:8518381
- 负责人:
- 金额:$ 28.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmino AcidsAromatic CompoundsAttenuatedBasic ScienceBehaviorBenzeneBindingBiochemicalBiologicalBiologyBiomedical ResearchBoronCationsChemicalsChemistryDevelopmentDrug resistanceElectron TransportEngineeringEnvironmentExhibitsFamilyGoalsGrowthIndolesInvestigationKnowledgeLifeMagnetismMethodsModelingMolecularMuramidaseNitrogenOrganismPharmaceutical PreparationsPhenylalaninePositioning AttributePreparationPropertyProteinsResearchSchemeShapesStructureStructure-Activity RelationshipSynthesis ChemistrySystemTimeTryptophanTryptophan SynthaseWorkbasedesigndrug developmentfitnessimprovedinterestnovelpathogenpharmacophoreprogramspublic health relevanceresearch and developmenttool
项目摘要
DESCRIPTION (provided by applicant): Boron-containing compounds have recently emerged as useful biologically active substances with unique mechanisms of action. This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Specifically, we are interested in 1,2-azaborine heterocycles, which are aromatic compounds isosteric with arenes. The broad utility and fundamental importance of arenes combined with the unique elemental and chemical features of boron make 1,2-azaborines attractive targets for biomedical investigations. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. We outline a synthetic program for the preparation of 1,2-azaborine derivatives, a physical organic program that uses a combined synthetic, structural, spectroscopic, and computational approach to address the aromaticity and reactivity of 1,2-azaborines, and a chemical biology program to establish the reactivity and interactions of BN heterocycles in a biological environment. Our proposed studies will enhance the fundamental understanding of the structure, bonding, and aromaticity the 1,2-azaborine heterocycle and illuminate the changes in the properties of classic aromatic organic molecules (e.g., benzene and indole) upon the replacement of a C=C bond with the isostructural inorganic B-N unit. The basic science resulting from the proposed work will bring new impetus to the chemistry of novel aromatics while at the same time promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles and new mechanistic tools for chemical biology.
PUBLIC HEALTH RELEVANCE: This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. The proposed basic research will yield new fundamental knowledge and promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles.
描述(由申请人提供):含硼的化合物最近已成为具有独特作用机理的有用的生物活性物质。该提案描述了一项旨在开发含硼氮的杂环(BN杂环)的合成化学计划。具体而言,我们对1,2-氮杂核杂环感兴趣,这是芳族化合物与竞技场的芳香化合物。竞技场的广泛效用和基本重要性与硼的独特元素和化学特征相结合,使生物医学研究具有1,2-azaborines的吸引人目标。对基于硼的药物的研究的潜在好处包括发现新型的硼特异性生物学活性机制,这些机制是通过常规有机分子无法实现的,并且靶向病原体对耐药性的发展减弱。我们概述了一个合成程序,用于制备1,2-亚恰当衍生物,该程序使用合成的合成,结构,光谱和计算方法来解决1,2- azaborines的芳香性和反应性,以及一种化学生物学程序来建立BN Heterogodiccles in Ateryodododics oficology Eromity oferications。我们提出的研究将增强对结构,键合和芳香性的基本理解,1,2-氮杂型杂环并阐明与等于ISROCTURATIAL INORETARINE INTORINARINGAIN ININGARINGAIN BN NITIT替换C = C键的经典芳香有机分子(例如苯和吲哚)的特性的变化。拟议工作所产生的基础科学将为新型芳香剂化学带来新的动力,同时促进具有改进的药理学特征和化学生物学的新机械工具的新型硼衍生的生物学活性化合物的设计和开发。
公共卫生相关性:该提案描述了一项旨在开发含硼氮的杂环(BN杂环)的合成化学方案。对基于硼的药物的研究的潜在好处包括发现新型的硼特异性生物学活性机制,这些机制是通过常规有机分子无法实现的,并且靶向病原体对耐药性的发展减弱。拟议的基础研究将产生新的基本知识,并促进具有改进的药理学特征的新的硼衍生的生物学活性化合物的设计和开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shih-Yuan Liu其他文献
Shih-Yuan Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shih-Yuan Liu', 18)}}的其他基金
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10387406 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10121469 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10455044 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10663272 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10263287 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity
新型氮杂硼啉衍生物有望消除对乙酰氨基酚的肝毒性
- 批准号:
8195745 - 财政年份:2011
- 资助金额:
$ 28.41万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
7949958 - 财政年份:2010
- 资助金额:
$ 28.41万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
9173274 - 财政年份:2010
- 资助金额:
$ 28.41万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
8733176 - 财政年份:2010
- 资助金额:
$ 28.41万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
8306276 - 财政年份:2010
- 资助金额:
$ 28.41万 - 项目类别:
相似国自然基金
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
催化不对称自由基反应合成手性α-氨基酸衍生物
- 批准号:22371216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
特定肠道菌种在氨基酸调控脂质代谢中的作用与机制研究
- 批准号:82300940
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群紊乱导致支链氨基酸减少调控Th17/Treg平衡相关的肠道免疫炎症在帕金森病中的作用和机制研究
- 批准号:82301621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氨基酸调控KDM4A蛋白N-末端乙酰化修饰机制在胃癌化疗敏感性中的作用研究
- 批准号:82373354
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Heme-Dependent Chemistry in Aromatic Oxidation
芳香族氧化中血红素依赖性化学
- 批准号:
10540085 - 财政年份:2014
- 资助金额:
$ 28.41万 - 项目类别:
Synthesis of Radiofluorinated PET Imaging Agents
放射性氟化 PET 显像剂的合成
- 批准号:
8495335 - 财政年份:2012
- 资助金额:
$ 28.41万 - 项目类别:
Synthesis of Radiofluorinated PET Imaging Agents
放射性氟化 PET 显像剂的合成
- 批准号:
8348513 - 财政年份:2012
- 资助金额:
$ 28.41万 - 项目类别:
Synthesis of Radiofluorinated PET Imaging Agents
放射性氟化 PET 显像剂的合成
- 批准号:
8666643 - 财政年份:2012
- 资助金额:
$ 28.41万 - 项目类别:
Understanding polyspecific drug binding in P-glycoprotein
了解 P-糖蛋白中的多特异性药物结合
- 批准号:
8365444 - 财政年份:2012
- 资助金额:
$ 28.41万 - 项目类别: